Traditionally, chemotherapy was given after surgery (primary cytoreductive surgery (PCRS) and adjuvant chemotherapy). However, chemotherapy can be used before surgery (neoadjuvant chemotherapy (NACT) ...

Trastuzumab Emtansine Improves Long-Term Survival in HER2 Breast Cancer Jan. 15, 2025 — In patients with high-risk HER2-positive breast cancer, post-surgery, or adjuvant, treatment with ...

15, 2025 — In patients with high-risk HER2-positive breast cancer, post-surgery, or adjuvant ... Imaging Technique Allows Rapid Assessment of Ovarian Cancer Subtypes and Their Response to ...

Despite all medical cautions, people are still using this because many consider it a safer way of treatment rather than surgery or ... black salve to treat her ovarian cancer, as per a report ...

Clea Shearer opens up to PEOPLE about the latest and unexpected surgery in her breast cancer journey, and how she’s using her ...

University of Virginia Cancer Center researchers have explained the failure of immune checkpoint therapy for ovarian cancer ...

University of Virginia Cancer Center researchers have explained the failure of immune checkpoint therapy for ovarian cancer by discovering how gut bacteria interfere with the treatment.

Opportunistic salpingectomy (OS) during any suitable abdominal surgery is effective for reducing the incidence of ovari ...

Researchers, led by the University of Melbourne's Professor Laura Mackay, a Laboratory Head and Immunology Theme Leader at ...

Background: Variable rates of HER2 protein overexpression and gene ... (fluorescence in situ hybridization [FISH] positive) ovarian cancer progressing under taxane/carboplatin chemotherapy or ...

A breast cancer ... surgery scars and built-in pockets for breast forms, but Melanie discovered the market lacked stylish and affordable choices. Determined to fill the gap, Melanie launched her ...

ImmunoGen, Inc. has announced that its platinum-resistant ovarian cancer drug ELAHERE (mirvetuximab soravtansine-gynx) has been granted FDA accelerated approval. This first FDA antibody-drug ...